Candel Therapeutics (CADL) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.74
-0.45
-0.16
0.13

Details

Expected EPS
-0.37462
Actual EPS
0.13
Surprise EPS
0.5
Surprise Percent
+134.7%

Description

⁨Candel Therapeutics⁩ (⁦CADL⁩) has reported earnings of ⁦0.13⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts